Hepatic arterial infusion chemotherapy in sarcoma liver metastases: A report of 6 cases

Tumori

Volumn 91, Issue 1, 2005, Pages 19-23

  Melichar, Bohuslav ^a   Vobořil, Zbyněk ^a   Nožička, Jan ^a   Cerman Jr , Jaroslav ^a   Melicharová, Karolina ^a   Mergancová, Jindřiška ^a   Filip, Stanislav ^a   Krajina, Antonín ^a   Vobořil, René ^a   Jandík, Pavel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Gastrointestinal stromal tumor; Hepatic arterial infusion; Leiomyosarcoma; Liver metastases

Indexed keywords

CISPLATIN; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; MESNA; MITOMYCIN C; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INFUSION; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; LIVER METASTASIS; MALE; OUTCOMES RESEARCH; PROGNOSIS; SARCOMA; SURVIVAL RATE;

EID: 20144389872     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160509100105     Document Type: Article

References (25)

1. Meta-Analysis Group in Cancer: Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst, 88: 252-258, 1996.
2. Earlam S, Glover C, Davies M, Fordy C, Allen-Mersh TG: Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients. J Clin Oncol, 15: 2022-2029, 1997.
3. Hafner GH, Rao U, Karakousis CP: Liver metastases from soft tissue sarcoma. J Surg Oncol, 58: 12-16, 1995.
4. Stehlin JS, de Ipolyi PD, Greeff PJ, McGaff CJ, Davis BR, McNary L: Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg, 208: 23-35, 1988.
5. Miettinen M, Lasota J: Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 438: 1-12, 2001.
6. Demetri GD, von Mehren M, Blanke CD, van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CDM, Joensuu H: Efficacy and safety of imabinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 347: 472-480, 2002.
7. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg, 141: 586-589, 1981.
8. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer. 47: 207-214, 1981.
9. Fiorentini G, Bernardesci P, De Simone M, Rossi S, Dentico P, Biancalani M, Scuderi S, Vaira M, Palomba A: Efficacy of imatinib mesylate in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy with epirubicin. J Exp Clin Cancer Res, 22 (Suppl): 13-16, 2003.
10. Mavligit GM, Zukwiski AA, Ellis LM, Chuang VP, Wallace S: Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer, 75: 2083-2088, 1995.
11. Ng EH, Pollock RE, Romsdahl MM: Prognostic implications of patterns of failure for gastrointestinal leiomyosarcoma. Cancer, 69: 1334-1341, 1992.
12. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival. Ann Surg, 231: 51-58, 2000.
13. Bedikian AY, Khankhanian N, Valdivieso M, Heilbrun LK, Benjamin RS, Yap BS, Nelson RS, Bodey GP: Sarcoma of the stomach: clinicopathologic study of 43 cases. J Surg Oncol, 13: 121-127, 1980.
14. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF: Results of hepatic resection for sarcoma metastatic to liver. Ann Surg. 234: 540-548, 2001.
15. Crosby JA, Catton CN, Davis A, Couture J, O'Sullivan B, Kandel R, Swallow CJ: Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol, 8: 50-59, 2001.
16. Van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, Verweij J, Santoro A, Buesa J, Tursz T: Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens: a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol, 17: 150-157, 1999.
17. DeMatteo RP, Heinrich MC, El-Rifai WM, Demetri G: Clinical management of gastrointestinal stromal tumors: before and after STI-571. Human Pathol, 33: 466-477, 2002.
18. Edmonson JH, Marks RS, Buckner JC, Mahoney MR: Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas. Cancer Invest, 20: 605-612, 2002.
19. Plaat BEC, Hollema H, Molenaar WM, Broers GHT, Pijpe J, Mastik MF, Hoekstra HJ, van den Berg E, Scheper RJ, van der Graaf WTA: Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol, 18: 3211-3220, 2000.
20. Rajan DJ, Soulen MC, Clark TWI, Baum RA, Haskal ZJ, Shlansky-Goldberg RD, Freiman DB: Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol chemoembolization. J Vase Interv Radiol, 12: 187-193, 2001.
21. Carson W, Karakousis C, Douglass H, Rao U, Palmer ML: Results of aggressive treatment of gastric sarcoma. Ann Surg Oncol, 1: 244-251, 1994.
22. Lang H, Nussbaum KT, Kaudel P, Fruhauf N, Flemming P, Raab R: Hepatic metastases from leiomyosarcoma. A single-center experience with 34 resections during a 15-year period. Ann Surg, 231: 500-505, 2000.
23. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, Theodore C, Bonvalot S, Lasser P: Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients. J Am Coll Surg, 187: 487-493, 1998.
24. Chen H, Pruitt A, Nicol TL, Gorgulu S, Choti MA: Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg, 2: 151-155, 1998.
25. Karavias DD, Tepetes K, Karatzas T, Felekouras E, Androulakis J: Liver resection for metastatic non-colorectal non-endocrine hepatic neoplasms. Eur J Surg Oncol, 28: 135-139, 2002.